Related Experiment Video
Updated: Aug 4, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
Hypothermia-induced coagulopathy during hemorrhagic shock
K R Krause1, G A Howells, C L Buhs
1Division of Trauma Surgery, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.
This study investigates how low body temperature affects blood clotting and heart function in pigs experiencing severe blood loss. Researchers found that cold conditions worsen heart performance and clotting ability more than blood loss alone, even after fluid replacement.
Area of Science:
- Trauma and critical care medicine research within hypothermia-induced coagulopathy
- Physiological monitoring in experimental surgery
Background:
No prior work had fully resolved the combined physiological impact of cold body temperatures and severe blood loss. It was already known that trauma patients often experience drops in core temperature. This uncertainty drove researchers to examine how these two states interact during resuscitation. Prior research has shown that blood clotting enzymes function poorly in cold environments. However, the specific additive nature of these stressors remained poorly defined in clinical settings. This gap motivated a controlled investigation using a porcine model. Previous studies often failed to isolate the influence of temperature from the severity of the initial injury. That uncertainty drove the need for a standardized approach to simulate blunt trauma and subsequent fluid management.
Purpose Of The Study:
The aim of this investigation was to determine the effect of cold body temperatures on hemodynamic, metabolic, and coagulation parameters during severe blood loss. Researchers sought to clarify how these two stressors interact within a controlled trauma model. The study specifically addressed whether low temperature alters the body's response to standard fluid resuscitation. This problem is significant because trauma patients frequently present with both blood loss and unintended cooling. The authors intended to isolate the physiological consequences of hypothermia from the initial injury severity. By comparing normothermic and hypothermic subjects, the team evaluated the persistence of clotting dysfunction. This motivation drove the need to assess whether volume replacement alone could correct the observed physiological deficits. The study provides evidence regarding the additive nature of these conditions in a standardized experimental setting.
Main Methods:
Review approach involved a controlled porcine model to simulate severe blunt injury and subsequent blood loss. Investigators maintained a consistent protocol for hemorrhage until systolic blood pressure reached thirty millimeters of mercury. The team then initiated simultaneous blood loss and crystalloid volume replacement to mimic clinical resuscitation. Researchers divided the subjects into two distinct groups to isolate the variable of core body temperature. One group underwent external cooling using ice, while the other remained normothermic throughout the procedure. The protocol included a final phase where hemorrhage and fluid administration were ceased to observe recovery. Data collection focused on hemodynamic performance and specific clotting time markers across both cohorts. This systematic design enabled the researchers to compare the physiological outcomes of cold-stressed subjects against those with normal temperatures.
Main Results:
Key findings from the literature demonstrate that cold body temperatures significantly exacerbate the reduction in cardiac output during blood loss. Hypothermic subjects experienced a more substantial decline in heart performance than their normothermic counterparts. Fluid resuscitation successfully restored cardiac output to baseline levels in the normothermic group. In contrast, cardiac output remained depressed in the hypothermic group despite receiving identical volume replacement. Clotting assessments revealed that prothrombin and partial thromboplastin times were significantly more prolonged in the cold-stressed animals. This clotting dysfunction persisted in the hypothermic group even after the replacement of shed blood. The normothermic group showed a return to normal clotting function following blood replacement, unlike the hypothermic subjects. These results suggest that the combined impact of shock and cold is additive rather than merely cumulative.
Conclusions:
Synthesis and implications suggest that cold body temperatures and severe blood loss exert additive negative effects on cardiovascular and clotting systems. The authors propose that these physiological impairments persist even after stopping blood loss and providing fluid resuscitation. Their findings indicate that standard volume replacement fails to restore normal heart function in cold-stressed subjects. The researchers suggest that clinical management must prioritize warming alongside traditional fluid therapy. This review of the evidence highlights that cooling exacerbates the severity of trauma-related physiological instability. The authors emphasize that addressing only one factor is insufficient for effective patient stabilization. Their work implies that clinicians should anticipate prolonged clotting dysfunction in patients presenting with both conditions. These results underscore the necessity of aggressive, simultaneous intervention for both shock and temperature regulation in trauma care.
Frequently Asked Questions
The researchers propose that cold temperatures and severe blood loss act additively to impair heart function and clotting. While normothermic subjects regained baseline cardiac output through fluid replacement, the hypothermic group showed persistent cardiac depression and significantly longer prothrombin and partial thromboplastin times.
The study utilized a porcine model to simulate severe blunt injury and subsequent blood loss. This approach allowed for the controlled comparison of seven hypothermic animals against seven normothermic counterparts during standardized hemorrhage and fluid resuscitation phases.
The researchers indicate that aggressive intervention is required for both conditions simultaneously. This necessity arises because the deleterious effects of cold on coagulation and cardiac output do not resolve simply by arresting hemorrhage or administering crystalloid volume replacement.
Crystalloid volume replacement served as the primary tool for evaluating recovery. In the normothermic group, this fluid restored cardiac output to baseline levels, whereas the hypothermic group exhibited a sustained, depressed cardiac output despite receiving identical volume resuscitation.
The team measured cardiac output, prothrombin times, and partial thromboplastin times. They observed that hypothermic subjects experienced a larger reduction in cardiac output and more pronounced prolongation of clotting times compared to those maintained at normal body temperatures.
The authors claim that the negative impact of low body temperature on hemodynamics and coagulation persists even after hemorrhage has been stopped. Consequently, they propose that clinicians must aggressively treat both conditions to mitigate these additive physiological threats.
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Hemorrhagic Stroke ll: Pathophysiology

